Clinical Trials Directory

Trials / Completed

CompletedNCT03164005

The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease

Status
Completed
Phase
Study type
Observational
Enrollment
194 (actual)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The investigators will enroll about 120 subjects from the hospital's healthcare center. The investigators will collect the basic informations, blood pressure, body mass index, fasting blood glucose and fasting blood lipids of each subject. The investigators will collect the blood samples and then test them for fasting insulin levels, VEGF-B levels, the gene promoter region methylation status and the genomic protein methylation levels of the VEGF-B gene of the cells,and finally do the statistical analysis.

Detailed description

The investigators will enroll about 120 subjects from the hospital's healthcare center, and these 120 subjects will be divided into four groups: normal weight with or without metabolic diseases and obesity with or without metabolic diseases. Each group has 30 subjects. The investigators will collect the basic information(name, gender,age, medical history,family history, etc.), blood pressure, body mass index, fasting blood glucose and fasting blood lipids of each subject from the healthcare center. The investigators will collect the blood samples of each subject,separate the plasma and then test the fasting insulin, VEGF-B levels by ELISA. The investigators will separate the peripheral blood mononuclear cells from the blood, and then test the gene promoter region methylation status of the VEGF -B gene by PCR and the bisulfite-modified sequencing and test the genomic protein methylation level of the VEGF-B gene by chromatin immunoprecipitation assay(CHIP) and real-time quantitative PCR of the cells,and finally do the statistical analysis.

Conditions

Timeline

Start date
2017-04-20
Primary completion
2017-09-01
Completion
2018-03-01
First posted
2017-05-23
Last updated
2021-04-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03164005. Inclusion in this directory is not an endorsement.